tiprankstipranks
Trending News
More News >
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Income Statement

Compare
178 Followers

Revelation Biosciences Income Statement

Last quarter (Q1 2025), Revelation Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Revelation Biosciences's net income was $-2.05M. See Revelation Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -25.05K$ -40.01K$ -69.17K$ 0.00
Operating Expenses
$ 7.98M$ 8.66M$ 10.86M$ 11.95M$ 145.49K
Depreciation and Amortization
$ 27.92K$ 25.05K$ 40.01K$ 69.17K$ 3.80M
EBITDA
$ -7.95M$ -95.21K$ -10.84M$ -11.93M$ -145.49K
Operating Income
$ -7.98M$ -8.66M$ -10.86M$ -11.95M$ -145.49K
Other Income/Expenses
$ -7.06M$ 8.54M$ 34.96K$ -36.35K$ -1.49M
Pretax Income
$ -15.04M$ -120.25K$ -10.83M$ -11.99M$ -1.63M
Net Income
$ -15.04M$ -120.25K$ -10.79M$ -11.99M$ -1.63M
Per Share Metrics
Basic EPS
$ -9.44$ -0.53$ -600.77$ -1.28K$ -188.18
Diluted EPS
$ -9.44$ -0.53$ -600.77$ -1.28K$ -188.18
Weighted Average Shares Outstanding
346.50K 228.00K 17.97K--
Weighted Average Shares Outstanding (Diluted)
346.50K 228.64K 17.97K--
Currency in USD

Revelation Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis